TADALAFIL LILLY 20 mg, film-coated tablet 4 tablets
Active ingredients: Tadalafil
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet4 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TADALAFIL LILLY 20 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium PVC de 4 comprimé(s)
- Marketing authorisation holder
- ELI LILLY NEDERLAND BV (PAY-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Apr 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65332662CIP73008748CIP133400930087480Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TADALAFILcomprimé | 20 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.